Coronavirus Notebook: Remdesivir Enters Study, Outspoken Physician's Death Sparks Anger
Condolences And Outrage Over Death
Gilead’s remdesivir is used for mild and moderate patients after an astonishing clinical approval in China, while the nation mourns the loss of an outspoken 34-year old physician died on Feb.6 of the virus.
You may also be interested in...
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
China insurance giant snatches up stakes in Japanese pharma and a traditional Chinese medicines maker with a $465m spending spree.
With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.